+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "TAVI"

From
Transcatheter Aortic Heart Valve Devices Market - Product Thumbnail Image

Transcatheter Aortic Heart Valve Devices Market

  • Report
  • June 2023
  • 10 Pages
  • Global
From
From
From
From
From
From
Mastering Structural Heart Disease. Edition No. 1 - Product Thumbnail Image

Mastering Structural Heart Disease. Edition No. 1

  • Book
  • February 2023
  • 672 Pages
Echo Made Easy. Edition No. 4 - Product Thumbnail Image

Echo Made Easy. Edition No. 4

  • Book
  • June 2024
Loading Indicator

Transcatheter Aortic Valve Implantation (TAVI) is a minimally invasive procedure used to treat aortic valve stenosis, a condition in which the aortic valve does not open properly. During the procedure, a catheter is inserted through a small incision in the groin and guided to the heart. A replacement valve is then inserted through the catheter and implanted in the aortic valve. TAVI is a relatively new procedure, having been approved by the FDA in 2011, and is an alternative to traditional open-heart surgery. TAVI is a rapidly growing market within the cardiovascular devices industry. It is a less invasive procedure than open-heart surgery, and is associated with fewer complications and shorter recovery times. It is also more cost-effective than traditional surgery, making it an attractive option for many patients. Some of the major companies in the TAVI market include Edwards Lifesciences, Medtronic, Boston Scientific, and Abbott. Show Less Read more